Point6 Bio
Point6 Bio

Point6 Bio

DR5Ahrefs DR: 5/100. Bottom 25%. Measured by Ahrefs. Median 44.Agent45Agent Readiness: 45/100. Above median. Measured by StartupHub.ai. Median 41.

Developing novel therapeutics for age-related diseases using senolytic compounds.

Website
2021ActiveCambridge, United States

About

Point6 Bio is a biotechnology company focused on developing innovative treatments for age-related diseases. They are specifically targeting cellular senescence, a key driver of aging and numerous chronic conditions, by developing senolytic compounds that selectively clear senescent cells.

Key facts

At-a-glance profile data

Website
point6.bio
Headquarters
Cambridge, United States
Founded
2021
Total funding
-
Business model
B2B

Tech stack

Detected on point6.bio, last scanned 24 Aug 2026. Run your own scan

Frontend
jQuery
SEO
Yoast SEO
CMS / Builders
WordPress
CDN
Cloudflare
Email provider
Google Workspace
Add first review